Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Aug 2;21(1):730.
doi: 10.1186/s12879-021-06399-8.

Economic and disease burden of RSV-associated hospitalizations in young children in France, from 2010 through 2018

C Demont  1 , N Petrica  2 , I Bardoulat  2 , S Duret  2 , L Watier  3 , A Chosidow  4 , M Lorrot  4 , A Kieffer  5 , M Lemaitre  2
Affiliations

Economic and disease burden of RSV-associated hospitalizations in young children in France, from 2010 through 2018

C Demont et al. BMC Infect Dis. .

Erratum in

Abstract

Background: Respiratory syncytial virus (RSV) is the main cause of infant and child hospitalizations. The study objective is to estimate the RSV-associated hospitalizations and economic burden in young children in France to inform future preventive strategies.

Methods: We conducted a retrospective analysis of RSV-associated hospitalizations data from the French Hospital database (PMSI-MCO) which covers the entire French population. All children aged < 5 years hospitalized with RSV ICD-10 codes (J210, J219, J45, J121, J205, R062) from 2010 to 2018, were included. Descriptive analyses were conducted by RSV seasons (Oct to March), by respiratory years (July to June) and per age groups.

Results: On average 45,225 RSV-associated hospitalizations (range: 43,715 - 54,616) per season was reported in France, 69% among children < 1 year old. This represents 28% of all-cause hospitalizations that occurred among children < 1 year old, and less than 10% of all-cause hospitalizations in older children. Number of RSV-associated hospitalizations were similar for infants born during (Oct-March) or outside (April-September) their first RSV season. The highest risk being reported for infants born from September through November. The associated hospitalization cost increased between 2010 - 11 and 2017-18, from €93.2 million to €124.1 million, respectively, and infants < 1 year old represented 80% of the economic burden.

Conclusion: RSV is an important cause of child hospitalization in France. The burden on healthcare system is mainly driven by < 1 year olds, and preventive strategies should be implemented before the first RSV season.

Keywords: Burden; Children; Hospitalization; Respiratory syncytial virus; Socio-economic impact.

PubMed Disclaimer

Conflict of interest statement

NP, SD, Magali Lemaitre and IB are employees of IQVIA. AK and CD are Sanofi employees and may hold shares and/or stock options in the company. AC, Mathie Lorrot and LW had received consulting fees from IQVIA for the study.

Figures

Fig. 1
Fig. 1
Rate of RSV-associated hospitalizations, per 1000 person-month, by RSV season and age group, from 2010 through 2018 in France
Fig. 2
Fig. 2
Impact of the month of birth on the risk of RSV-associated hospitalization (RSV-specific ICD-10 codes) from 2010 through 2018 in France
Fig. 3
Fig. 3
RSV associated hospitalization cost distribution by age group during RSV seasons from 2010 through 2018 in France
See this image and copyright information in PMC

References

    1. Shi T, McAllister DA, O’Brien KL, Simoes EAF, Madhi SA, Gessner BD, et al. Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in young children in 2015: a systematic review and modelling study. Lancet. 2017;390(10098):946–958. doi: 10.1016/S0140-6736(17)30938-8. - DOI - PMC - PubMed
    1. Paes BA, Mitchell I, Banerji A, Lanctôt KL, Langley JM. A decade of respiratory syncytial virus epidemiology and prophylaxis: translating evidence into everyday clinical practice. Can Respir J. 2011;18(2):e10–e19. doi: 10.1155/2011/493056. - DOI - PMC - PubMed
    1. Bont L, Checchia PA, Fauroux B, Figueras-Aloy J, Manzoni P, Paes B, Simões EAF, Carbonell-Estrany X. Defining the epidemiology and burden of severe respiratory syncytial virus infection among infants and children in Western countries. Infect Dis Ther. 2016;5(3):271–298. doi: 10.1007/s40121-016-0123-0. - DOI - PMC - PubMed
    1. Blanken MO, Rovers MM, Molenaar JM, Winkler-Seinstra PL, Meijer A, Kimpen JLL, Bont L. Respiratory syncytial virus and recurrent wheeze in healthy preterm infants. N Engl J Med. 2013;368(19):1791–1799. doi: 10.1056/NEJMoa1211917. - DOI - PubMed
    1. Hall CB, Weinberg GA, Iwane MK, Blumkin AK, Edwards KM, Staat MA, Auinger P, Griffin MR, Poehling KA, Erdman D, Grijalva CG, Zhu Y, Szilagyi P. The burden of respiratory syncytial virus infection in young children. N Engl J Med. 2009;360(6):588–598. doi: 10.1056/NEJMoa0804877. - DOI - PMC - PubMed